Who
Charles Atkinson
EVP, General Counsel & Sec.
Company insider
Files Form 4 as: EVP, General Counsel & Sec., Perrigo Company.
In numbers
- Trades disclosed
- 12
- Buys
- 1
- Sells
- 0
- Bought
- $23K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Jun 2025
- Last trade
- 8 Jul 2026
- Last filed
- 10 Jul 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jul 2026filed 10 Jul 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,704 | filing |
| 8 Jul 2026filed 10 Jul 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,704 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $72K6,690 at $10.83 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code F | $20K1,835 at $10.83 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,690 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,690 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $72K6,690 at $10.83 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code F | $20K1,835 at $10.83 | filing |
| 13 May 2026filed 15 May 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,093 | filing |
| 13 May 2026filed 15 May 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,093 | filing |
| 5 Sep 2025filed 9 Sep 2025 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Bought | $23K1,000 at $23.20 | filing |
| 6 Jun 2025filed 10 Jun 2025 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,069 | filing |
News
Ovid Therapeutics (NASDAQ:OVID) and Perrigo (NYSE:PRGO) Head to Head ReviewPRGO · themarketsdaily.com · 20 Oct 2026Contrasting Neurocrine Biosciences (NASDAQ:NBIX) and Perrigo (NYSE:PRGO)PRGO · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Charles Atkinson; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.